Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Obstet Gynecol Scand ; 56(4): 419-26, 1977.
Article in English | MEDLINE | ID: mdl-146393

ABSTRACT

Reconstructive oviductal surgery was performed on 205 private patients with primary and secondary infertility, who were selected from 1075 endoscopic examinations. Each patient underwent an infertility survey which included gamete formation, reception and deposition of gametes, nidation, post-coital, and semen analysis. Only those with tubal abnormalities, not responding to conservative therapy after a minimum period of six months following laparoscopic examination, were selected for tuboplasty. Spiral stents for fimbrioplasty and straight teflon tubing for mid-portion and cornua obstruction were employed. These stents were removed eight weeks post-surgery, under local anesthesia at the office. Of the 205 tuboplasties, 193 patients had sustained patency; 75 conceived; 7 aborted; and 1 had an ectopic pregnancy. Pregnancy occurred between 1 and 26 months after removal of the stents. Complications were very few. The use of Roland spiral teflon stents has resulted in a greater percentage in patency and pregnancy rates, as compared to those without use of stents.


Subject(s)
Fallopian Tubes/surgery , Infertility, Female/surgery , Female , Humans , Hysterosalpingography , Infertility, Female/diagnosis , Laparoscopy , Methods , Pregnancy
3.
Obstet Gynecol ; 46(3): 308-10, 1975 Sep.
Article in English | MEDLINE | ID: mdl-1161234

ABSTRACT

In a continuing oral contraceptive study of d-norgestrel, the 1,0-mg dose--the dose previously found to give the best cycle control--was administered cyclically on a "21-7 day" schedule to 284 women during 2650 cycles. None of the women conceived, and cycle control, though often altered, was generally acceptable. Side effects were minimal, and laboratory determinations performed prior to and during the administration of this agent revealed no clinically significant changes.


Subject(s)
Norgestrel/administration & dosage , Adolescent , Adult , Amenorrhea/chemically induced , Blood Pressure , Body Weight , Cervix Uteri/cytology , Drug Evaluation , Female , Humans , Hypertension/chemically induced , Menstruation , Menstruation Disturbances/chemically induced , Norgestrel/adverse effects , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...